Elutia Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|---|
| ABBV | AbbVie | Outperform |
9
|
$166.42 | Buy/Sell | $178.42 | 9.66% | 11 | $293.88B |
| ABT | Abbott Laboratories | Outperform |
9
|
$104.09 | Buy/Sell | $118.92 | 21.53% | 7 | $181.08B |
| SYK | Stryker Corp | Outperform |
10
|
$334.68 | Buy/Sell | $353.16 | 12.35% | 24 | $127.50B |
| MDT | Medtronic | Outperform |
11
|
$85.92 | Buy/Sell | $92.47 | 11.73% | 9 | $114.09B |
| EW | Edwards Lifesciences Corp | Outperform |
11
|
$89.14 | Buy/Sell | $91.18 | 12.18% | 5 | $53.72B |
| 4543 | Terumo | Outperform |
18
|
¥5.63k | Buy/Sell | ¥4.97k | -9.46% | 0 | ¥3.76T |
| BAX | Baxter International Inc | Hold |
17
|
$35.25 | Buy/Sell | $44.86 | 24.82% | 5 | $17.96B |
| SN. | Smith & Nephew | Outperform |
18
|
£10.24 | Buy/Sell | £16.09 | 58.59% | 10 | £8.73B |
| IART | Integra LifeSciences Holdings | Hold |
16
|
$27.54 | Buy/Sell | $46.60 | -7.41% | 4 | $1.82B |
| LMAT | LeMaitre Vascular | Outperform |
18
|
$78.45 | Buy/Sell | $59.86 | -1.85% | 0 | $1.45B |
| AORT | Artivion | Buy |
12
|
$23.46 | Buy/Sell | $24.15 | 9.76% | 0 | $878.83M |
| AVR | Anteris Technologies Ltd | Buy |
10
|
$19.61 | Buy/Sell | $28.00 | 52.98% | 0 | $408.99M |